237 related articles for article (PubMed ID: 27244685)
1. Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis.
Lin KH; Ho YH; Chiang JC; Li MW; Lin SH; Chen WM; Chiang CL; Lin YN; Yang YJ; Chen CN; Lu J; Huang CJ; Tigyi G; Yao CL; Lee H
Sci Rep; 2016 May; 6():27050. PubMed ID: 27244685
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic acid receptors 2 and 3 regulate erythropoiesis at different hematopoietic stages.
Chiang JC; Chen WM; Lin KH; Hsia K; Ho YH; Lin YC; Shen TL; Lu JH; Chen SK; Yao CL; Chen BPC; Lee H
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158818. PubMed ID: 33035680
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of lysophosphatidic acid receptors 2 and 3 regulates myeloid commitment of hematopoietic stem cells.
Lin KH; Chiang JC; Chen WM; Ho YH; Yao CL; Lee H
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C509-C519. PubMed ID: 33406026
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid induces erythropoiesis through activating lysophosphatidic acid receptor 3.
Chiang CL; Chen SS; Lee SJ; Tsao KC; Chu PL; Wen CH; Hwang SM; Yao CL; Lee H
Stem Cells; 2011 Nov; 29(11):1763-73. PubMed ID: 21915944
[TBL] [Abstract][Full Text] [Related]
5. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
[TBL] [Abstract][Full Text] [Related]
6. Activation of Lysophosphatidic Acid Receptor 3 Inhibits Megakaryopoiesis in Human Hematopoietic Stem Cells and Zebrafish.
Lin KH; Li MW; Chang YC; Lin YN; Ho YH; Weng WC; Huang CJ; Chang BE; Yao CL; Lee H
Stem Cells Dev; 2018 Feb; 27(3):216-224. PubMed ID: 29239275
[TBL] [Abstract][Full Text] [Related]
7. Opposing regulation of megakaryopoiesis by LPA receptors 2 and 3 in K562 human erythroleukemia cells.
Ho YH; Yao CL; Lin KH; Hou FH; Chen WM; Chiang CL; Lin YN; Li MW; Lin SH; Yang YJ; Lin CC; Lu J; Tigyi G; Lee H
Biochim Biophys Acta; 2015 Feb; 1851(2):172-83. PubMed ID: 25463482
[TBL] [Abstract][Full Text] [Related]
8. Effects of lysophosphatidic acid (LPA) receptor-2 (LPA
Ueda N; Minami K; Ishimoto K; Tsujiuchi T
Cell Signal; 2020 May; 69():109551. PubMed ID: 32006610
[TBL] [Abstract][Full Text] [Related]
9. Specific LPA receptor subtype mediation of LPA-induced hypertrophy of cardiac myocytes and involvement of Akt and NFkappaB signal pathways.
Chen J; Chen Y; Zhu W; Han Y; Han B; Xu R; Deng L; Cai Y; Cong X; Yang Y; Hu S; Chen X
J Cell Biochem; 2008 Apr; 103(6):1718-31. PubMed ID: 17891781
[TBL] [Abstract][Full Text] [Related]
10. Regulation of cellular responses to X-ray irradiation through the activation of lysophosphatidic acid (LPA) receptor-3 (LPA
Ikeda H; Takai M; Yashiro N; Amano Y; Hara K; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 May; 257():155293. PubMed ID: 38615508
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid receptor LPA
Chen WM; Chiang JC; Lin YC; Lin YN; Chuang PY; Chang YC; Chen CC; Wu KY; Hsieh JC; Chen SK; Huang WP; Chen BPC; Lee H
Aging Cell; 2020 Jan; 19(1):e13064. PubMed ID: 31714004
[TBL] [Abstract][Full Text] [Related]
12. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
13. Participation of analogues of lysophosphatidic acid (LPA): oleoyl-sn-glycero-3-phosphate (L-alpha-LPA) and 1-oleoyl-2-O-methyl-rac-glycerophosphothionate (OMPT) in uterine smooth muscle contractility of the pregnant pigs.
Markiewicz W; Kamińska K; Bogacki M; Maślanka T; Jaroszewski J
Pol J Vet Sci; 2012; 15(4):635-43. PubMed ID: 23390752
[TBL] [Abstract][Full Text] [Related]
14. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
[TBL] [Abstract][Full Text] [Related]
15. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.
Jiang G; Inoue A; Aoki J; Prestwich GD
Bioorg Med Chem Lett; 2013 Mar; 23(6):1865-9. PubMed ID: 23395664
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis.
Huang YX; Lin KH; Chiang JC; Chen WM; Lee H
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397002
[TBL] [Abstract][Full Text] [Related]
17. Differential targeting of lysophosphatidic acid LPA
Olianas MC; Dedoni S; Onali P
Eur J Pharmacol; 2023 Nov; 959():176064. PubMed ID: 37758013
[TBL] [Abstract][Full Text] [Related]
18. Interplay between LPA2 and LPA3 in LPA-mediated phosphatidylserine cell surface exposure and extracellular vesicles release by erythrocytes.
Hasse S; Duchez AC; Fortin P; Boilard E; Bourgoin SG
Biochem Pharmacol; 2021 Oct; 192():114667. PubMed ID: 34216604
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
20. Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury.
Okusa MD; Ye H; Huang L; Sigismund L; Macdonald T; Lynch KR
Am J Physiol Renal Physiol; 2003 Sep; 285(3):F565-74. PubMed ID: 12770838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
